Amylin Pharmaceuticals News

It also provides disease prevention products, acute and chronic pain management products and insulin skin patches for diabetes.

On May 9 a woman filed a lawsuit against drug makers Amylin Pharmaceuticals and Eli Lilly in federal court, alleging that the companies failed to adequately warn her about type 2 diabetes drug Byetta's link to thyroid cancer, according to court documents for Childress v. Amylin Pharmaceuticals LLC, et al., No.

ResMed has only reached a small percentage of people who could benefit from its breathing assistance devices, Farrell said in an interview last week at ResMed headquarters.

Some of San Diego's biggest names in life science companies are vanishing. And while the region has endured such events before, the shifts are sudden and immense.

<![CDATA[INDIANAPOLIS - Eli Lilly and Co. reported better-than-expected earnings for the first quarter and said regulators had agreed to a fast-track review of its potential stomach cancer treatment. But shares fell $2.28. Analysts said the fast-track review was largely expected, a one-time tax credit buttressed Lilly's performance, and its revenue came in flat compared with last year. "I just think there wasn't a ton of good news there," Edward Jones analyst Judson Clark said. Lilly's earnings jumped 53 percent in the quarter, largely due to a $495 million payment for the transfer to former drug development partner Amylin Pharmaceuticals of commercial rights outside the United States for the diabetes treatment exenatide. Overall, Lilly earned $1.55 billion, or $1.42 per share. Revenue stayed flat at $5.6 billion. INDIANAPOLIS - WellPoint shares hit their highest level since the summer of 2011 on Wednesday after the nation's second largest health insurer trumped first-quarter earnings expectations, raised its 2013 forecast and said it could profit immediately from a key health care overhaul coverage expansion next year. The Indianapolis company's performance to start 2013 followed a year marked by slumping earnings, a forecast cut and the abrupt departure of former CEO Angela Braly. "We believe this turnaround story is making progress," BMO Capital Markets analyst Jennifer Lynch said in a research note. WellPoint Inc.'s first-quarter earnings rose about 3 percent to $885.2 million, or $2.89 per share. That compares to $856.5 million, or $2.53 per share, a year ago. Adjusted earnings totaled $2.94 per share, not counting investment gains. * Mike Raisor Ford is hosting a ribbon-cutting ceremony Thursday to celebrate the grand opening of Raisor Ford's new Quick Lane Service Center at noon. The center is located at 3960 Indiana 38 East in Lafayette. The facility has hired nine people as a result of the expansion. * The Tippecanoe County Chapter of the American Red Cross is hosting its 13th annual golf tournament on May 1. The event will raise money for the Heroes campaign. The goal is $80,000. Call 765-742-6975 or visit www.redcross.org/in/lafayette. * There will be a free business seminar from 8:30 a.m. to 11 a.m. April 30 at Huntington Bank, 1010 N. Fourth St., Lafayette. The seminar will teach participants about how to develop a business. Michael Kaplan, a professional business coach, will lead the discussion. To register, call Corey VanDenBerg at corey.vandenberg@huntington.com or call 765-742-1797. -- Staff and wire reports Send items to Hayleigh Colombo by email at hcolombo@jconline.com.

Eli Lilly & Co. said first-quarter profit exceeded analysts' estimates as the company cut jobs and had a lower tax rate from the reinstatement of a research and development credit.

Dr. David Hohn will be the new chairman of the board at Cleveland BioLabs Inc., replacing Dr.